116 related articles for article (PubMed ID: 10633935)
1. [Recent progress in the curative surgical treatment of stomach cancer].
Gouzi JL; Pradère B; Bloom E; Julio C; Seulin P; Carrère N
Ann Chir; 1999; 53(9):874-82. PubMed ID: 10633935
[TBL] [Abstract][Full Text] [Related]
2. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
3. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
4. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of and therapy for gastric cancer--work-flow].
Grundmann RT; Hölscher AH; Bembenek A; Bollschweiler E; Drognitz O; Feuerbach S; Gastinger I; Hermanek P; Hopt UT; Hünerbein M; Illerhaus G; Junginger T; Kraus M; Meining A; Merkel S; Meyer HJ; Mönig SP; Piso P; Roder J; Rödel C; Tannapfel A; Wittekind C; Woeste G
Zentralbl Chir; 2009 Aug; 134(4):362-74. PubMed ID: 19688686
[TBL] [Abstract][Full Text] [Related]
6. Extended lymphadenectomy in gastric cancer: when, for whom and why.
Roukos DH
Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
[TBL] [Abstract][Full Text] [Related]
7. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of stomach cancer: analysis of our personal experience].
Leggeri A; Roseano M; Bortul M; Calligaris L
Chir Ital; 1997; 49(3):15-20. PubMed ID: 9612647
[TBL] [Abstract][Full Text] [Related]
9. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
10. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval.
Miura S; Kodera Y; Fujiwara M; Ito S; Mochizuki Y; Yamamura Y; Hibi K; Ito K; Akiyama S; Nakao A
J Am Coll Surg; 2004 Jun; 198(6):933-8. PubMed ID: 15194075
[TBL] [Abstract][Full Text] [Related]
12. Perigastric lymph node status can be a simple prognostic parameter in patients with gastric cancer.
Kim TH; Han SU; Cho YK; Kim MW
Hepatogastroenterology; 2000; 47(35):1475-8. PubMed ID: 11100380
[TBL] [Abstract][Full Text] [Related]
13. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
[TBL] [Abstract][Full Text] [Related]
15. Re-study of gastric cancer: analysis of outcome.
Samson PS; Escovidal LA; Yrastorza SG; Veneracion RG; Nerves MY
World J Surg; 2002 Apr; 26(4):428-33. PubMed ID: 11910474
[TBL] [Abstract][Full Text] [Related]
16. [Lymph node excision in cancer of the stomach].
Msika S
J Chir (Paris); 1998 Oct; 135(4):155-61. PubMed ID: 9827394
[TBL] [Abstract][Full Text] [Related]
17. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
18. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
